Bottom line
How much do GGHCX and SCHLX overlap?
51% of their top holdings overlap by weight. 9 securities appear in both funds' top 25, making up 41.4% of GGHCX's assets and 45.6% of SCHLX's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings GGHCX and SCHLX have in common
| Holding | % of GGHCX | % of SCHLX | Overlap |
|---|---|---|---|
| Eli Lilly and Co. | 10.59% | 13.85% | 10.59% |
| Johnson & Johnson | 6.76% | 6.19% | 6.19% |
| UnitedHealth Group Inc. | 6.17% | 5.73% | 5.73% |
| Merck & Co., Inc. | 4.59% | 4.85% | 4.59% |
| AbbVie Inc. | 4.03% | 4.90% | 4.03% |
| Gilead Sciences, Inc. | 3.63% | 2.78% | 2.78% |
| Cardinal Health, Inc. | 2.10% | 1.34% | 1.34% |
| Vertex Pharmaceuticals Inc. | 2.01% | 2.45% | 2.01% |
| Thermo Fisher Scientific Inc. | 1.55% | 3.46% | 1.55% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in GGHCX
- Invesco Private Prime Fund — 4.67%
- argenx SE — 3.24%
- CVS Health Corp. — 2.52%
- Welltower Inc. — 2.34%
- BrightSpring Health Services, Inc. — 2.20%
- Royalty Pharma PLC — 2.13%
- Guardant Health, Inc. — 2.04%
- Invesco Private Government Fund — 1.80%
- Axsome Therapeutics, Inc. — 1.58%
- Edwards Lifesciences Corp. — 1.56%
- Invesco Treasury Portfolio — 1.56%
- BridgeBio Pharma, Inc. — 1.43%
- Waters Corp. — 1.41%
- IQVIA Holdings Inc. — 1.32%
- U C B S.a. — 1.24%
Only in SCHLX
- AstraZeneca PLC — 3.80%
- Novartis AG — 2.90%
- Amgen Inc — 2.88%
- Intuitive Surgical Inc — 2.69%
- Stryker Corp — 2.61%
- Abbott Laboratories — 2.39%
- Danaher Corp — 2.13%
- Boston Scientific Corp — 2.10%
- McKesson Corp — 2.05%
- Novo Nordisk A/S — 1.73%
- Medtronic PLC — 1.54%
- Bristol-Myers Squibb Co — 1.50%
- Regeneron Pharmaceuticals Inc — 1.43%
- Cencora Inc — 1.26%
- Roche Holding AG — 1.24%
Asset mix
| Asset type | GGHCX | SCHLX |
|---|---|---|
| Stocks | 97.5% | 99.6% |
| Cash & short-term funds | 8.8% | 0.5% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)
Country mix
| Country | GGHCX | SCHLX |
|---|---|---|
| US | 93.5% | 85.7% |
| CH | 2.7% | 5.2% |
| GB | 3.1% | 3.8% |
| NL | 3.4% | 1.0% |
| DK | 1.1% | 1.7% |
| IE | 0.6% | 1.5% |
| BE | 1.2% | — |
| FR | — | 1.0% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)
Check another pair
FAQ
How much do GGHCX and SCHLX overlap?
What stocks do GGHCX and SCHLX have in common?
Should I own both GGHCX and SCHLX?
Which holds more stocks, GGHCX or SCHLX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.